Teleflex Incorporated Stock News

Teleflex Incorporated (NYSE:TFX) shares, rose in value on Friday, 11/26/21, with the stock price down by -3.97% to the previous days close as strong demand from buyers drove the stock to $305.15. Actively observing the price movement in the last trading, the stock closed the session at $317.77, falling within a range of $304.57 and Is Teleflex Incorporated (NYSE: TFX) A Good Pick For New Investors Now? Read More »

WAYNE, Pa., Nov. 26, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced a worldwide recall of Arrow-Trerotola Over-The-Wire PTD® Kit Percutaneous Thrombolytic Device: 7FR. The Arrow-Trerotola Percutaneous Thrombolytic Device (PTD) Catheter, in conjunction with the Arrow Rotator Drive Unit, permits mechanical declotting of native arterio-venous (AV) fistulae and synthetic dialysis grafts.

Wall Street analysts expect Teleflex Incorporated (NYSE:TFX) to announce $750.89 million in sales for the current quarter, Zacks reports. Ten analysts have provided estimates for Teleflexs earnings. The lowest sales estimate is $741.95 million and the highest is $765.88 million. Teleflex reported sales of $711.18 million in the same quarter last year, which indicates a []

Stem cell concentration system further helps to obtain viability and proliferative potential of stem cell expected to gaining more traction and drive the stem cell concentration system market. The Global Stem Cell Concentration System Market Report provides planned insights into the

Teleflex Incorporated (TFX) shares closed today at 1.6% above its 52 week low of $312.68, giving the company a market cap of $14B. The stock is currently down 23.1% year-to-date, down 15.2% over the past 12 months, and up 113.4% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 0.2%. Trading Activity Trading volume this week was 28.8% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -233.8% The company's stock price performance over the past 12 months lags the peer average by -147.5% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 765.4% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Anesthesia Video Laryngoscope market research report serves a lot of parameters and detailed data about healthcare industry. The report endows with the steadfast knowledge and information of revolutionizing market landscape, what already exists in the market, future trends or what

Teleflex Incorporated (NYSE:TFX)s share price hit a new 52-week low during trading on Friday . The stock traded as low as $325.34 and last traded at $325.59, with a volume of 1831 shares changing hands. The stock had previously closed at $329.99. TFX has been the subject of several recent research reports. Zacks Investment Research []

Wall Street analysts expect Teleflex Incorporated (NYSE:TFX) to post earnings per share of $3.54 for the current quarter, according to Zacks. Ten analysts have issued estimates for Teleflexs earnings, with the highest EPS estimate coming in at $3.63 and the lowest estimate coming in at $3.49. Teleflex posted earnings of $3.25 per share in the []

Las Vegas, USA, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Urinary Catheters Market is Anticipated to Grow at a Tremendous CAGR of 6.63% and is Expected to Expand to USD 4.55 Billion by 2026, Asserts DelveInsight As per DelveInsight Analysis for Urinary Catheters market, the escalating prevalence of urological disorders such as urinary incontinence, benign prostatic hyperplasia, and urinary strictures, among others, and growing surgical procedures worldwide are some of the key factors, which are anticipated to increase the overall demand of Urinary Catheters, thereby augmenting the growth of Urinary Catheters market. DelveInsight''s Urinary Catheters Market Insights and Forecast report provides the current and forecast Urinary Catheters, upcoming innovation in the devices, individual market shares of the devices, challenges, drivers and barriers, market trends, and key competitors in the Urinary Catheters. Some of the essential takeaways from the Urinary Catheters Market report: As per an analysis by DelveInsight, North America is expected to dominate the overall Urinary Catheters Market during the forecast period.

Global Nephrostomy Guidewires Market Overview: The universal Nephrostomy Guidewires Market report gives us an in-depth overview of the research trends for the financial year 2021. The base year for calculation in the report is taken as 2020 while the historic year

WAYNE, Pa., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, has announced it was named a winner in the MedReps.com Best Places to Work in Medical Sales 2022 survey, earning the Number 1 spot for large companies and making this the fifth consecutive year the company has been on the list.

WAYNE, Pa., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Thomas Powell, Executive Vice President and CFO, Teleflex Incorporated (NYSE: TFX), is pleased to participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference. From November 22 nd to December 2 nd , 2021, registered attendees can access a pre-recorded presentation via the Piper Sandler conference site. Teleflex will be participating in 1x1 meetings on December 2, 2021. Investor meetings can be requested exclusively via Piper Sandler.

Related Stocks: V , XOM , DVN , RY , FB , PBR , CRM , ALC , ZI , MA , MPWR , SNAP , BABA , HUM , BAC , LRCX , VALE , NTES , AEO , LEVI , X , NUE , TFX ,

This Respiratory Therapy Equipment market report depicts industrial analysis, growth factors, driving factors and recent market trends, which greatly benefit to the newly entering key players in the industry. This market report is very important for them as it covers

Related Stocks: ICLR , TMO , GLOB , HTGC , OMCL , TECH , MRVI , DOCS , MRNA , AVTR , STLD , CPRI , BRK.B , SMG , TKR , PNR , TFX , GM ,